Geron receives milestone payment from Merck
Geron has received a $4 million milestone payment from Merck on account of the filing, and is eligible to receive additional development milestones as well as royalties on
Biologics contract development and manufacturing organisation (CDMO) AsymBio is set to secure 1.2397bn yuan (approximately $184m) from Asymchem Group, Hillhouse Qirui and other investors to support its long-term growth.